BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-686@pharmaconomics
DTSTAMP:20260707T030140Z
DTSTART;VALUE=DATE:20220930
DTEND;VALUE=DATE:20221001
SUMMARY:FENC Approval — PEDMARK (estimated date)
DESCRIPTION:A final FDA approval decision on PEDMARK for reduce the risk of ototoxicity associated with cisplatin in pediatric patients 1 month of age and older with localized\, non-metastatic solid tumors is expected ~ Sep 30\, 2022.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1211583/000110465926033885/fencf-20260324xex99d1.htm\n\nTrack it: https://pharmaconomics.com/e/686
URL:https://pharmaconomics.com/e/686
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:FENC catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR